CVRx Raises $65 Million

CVRx Inc., a Maple Grove, Minn.-based developer of an implantable device designed to control hypertension, has raised $65 million in Series D funding. Johnson & Johnson Development Corp. led the deal, and was joined by BBT Fund and return backers New Enterprise Associates, Thomas Weisel Healthcare Venture Partners, InterWest Partners, ABS Ventures, Frazier Healthcare Ventures and SightLine Partners. CVRx has now raised just over $125 million in total VC funding since its 2000 inception.